Grassroots Innovation: A Promising Innovation Paradigm for Pharmaceutical Companies - Innovation and Marketing in the Pharmaceutical Industry - page 147

Ryan RM, Deci EL (2000) Self-determination theory and the facilitation of intrinsic motivation,
social development and well-being. Am Psychol 55(1):68-78
Schaufeli WB, Bakker AB (2004) Job demands, job resources, and their relationship with burnout
and engagement: a multi-sample study. J Organ Behav 25:293-315
Selznick P (1949) TVA and the grass roots: a study in the sociology of formal organization.
University of California Press, Berkeley, CA
Stremersch S (2008) Health and marketing: the emergence of a new fi eld of research. Int J Res
Market 25:229-233
Stremersch S, Van Dyck W (2009) Marketing of the life sciences: a new framework and research
agenda for a nascent fi eld. J Market 73:4-30
Stremersch S, Lemmens A (2009) Sales growth of new pharmaceuticals across the globe: the role
of regulatory regimes. Market Sci 28(4):690-708
Sykes HB (1992) Incentive compensation for corporate venture personnel. J Bus Venturing
7:253-265
Terwiesch C, Ulrich K (2009) Innovation tournaments: creating and selecting exceptional oppor-
tunities. Harvard Business School, Boston, MA
Tellis GJ, Prabhu JC, Chandy RK (2009) Radical innovation across nations: the preeminence of
corporate culture. J Market 73:3-23
Verniers I, Stremresch S, Croux C (2011) The global entry of new pharmaceuticals: a joint inves-
tigation of launch window and price. Int J Res Market 28:295-308
von Hippel E (2005) Democratizing innovation. MIT Press, Cambridge, MA
von Hippel E (1988) The sources of innovation. Oxford University Press, Oxford
Wuyts S, Dutta S, Stremresch S (2004) Portfolios of interfi rm agreements in technology-intensive
markets: consequences for innovation and profi tability. J Market 68:88-100
Zahra SA (1993) Environment, corporate entrepreneurship and fi nancial performance: a taxo-
nomic approach. J Bus Venturing 8:319-340